NCT02489773View on ClinicalTrials.gov

Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Diabetes
Trial Locations (8)

Unknown

National Research Institute - Huntington Park, Los Angeles

National Research Institute-Westlake, Los Angeles

Kentucky Diabetes Endocrinology Center, Lexington

Tulane University, New Orleans

University of Nebraska Medical Center, Omaha

Texas Diabetes & Endocrinology, P.A. -Austin, Austin

Dallas Diabetes and Endocrine Center, Dallas

Capital Clinical Research Center, Olympia

All Listed Sponsors
lead

Asahi Kasei Pharma Corporation

INDUSTRY

NCT02489773 - Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study | Biotech Hunter | Biotech Hunter